Literature DB >> 10993652

Retinoblastoma protein-initiated cellular growth arrest overcomes the ability of cotransfected wild-type p53 to induce apoptosis.

H Shinohara1, J Zhou, K Yoshikawa, S Yazumi, K Ko, Y Yamaoka, T Mizukami, T Yoshida, S Akinaga, T Tamaoki, H Motoda, W F Benedict, R Takahashi.   

Abstract

The retinoblastoma gene, RB, participates in the regulation of the G1/S-phase transition and in p53-mediated apoptosis. We have previously reported that stably transfected RB functions as a growth and tumour suppressor in HTB9 human bladder carcinoma cells, which carry a mutation of the p53 gene at codon 280 and lack RB expression. To elucidate the potential role of RB in the regulation of p53-mediated apoptosis, we transfected a wt p53 expression plasmid under the control of the human cytomegalovirus promoter into parental and RB-transfected HTB9 cells. The p53(+)/RB(-)cells were susceptible to apoptosis under various experimental conditions: 1) incubation in serum-free culture for 72 h, 2) short-term (6 h) or long-term (48 h) exposure to etoposide, and 3) culturing in soft agar. In contrast, p53(+)/RB(+)cells were significantly resistant to apoptosis under similar conditions and exhibited efficient growth arrest, as measured by laser scanning cytometry. Tumorigenicity in nude mice of parental HTB9 cells was lost by exogenous expression of wt p53. Likewise, none of mice injected subcutaneously with either p53(-)/RB(+)or p53(+)/RB(+)cells developed tumours, indicating that RB allows suppression of tumorigenesis, regardless of p53 status. These results suggest that the growth-inhibitory function of RB may overcome the ability of wt p53 to induce apoptosis. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993652      PMCID: PMC2363552          DOI: 10.1054/bjoc.2000.1411

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins.

Authors:  E White; R Cipriani; P Sabbatini; A Denton
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

2.  Microscope-based multiparameter laser scanning cytometer yielding data comparable to flow cytometry data.

Authors:  L A Kamentsky; L D Kamentsky
Journal:  Cytometry       Date:  1991

Review 3.  The retinoblastoma protein pathway in cell cycle control and cancer.

Authors:  J Bartek; J Bartkova; J Lukas
Journal:  Exp Cell Res       Date:  1997-11-25       Impact factor: 3.905

4.  Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

Authors:  P Shaw; R Bovey; S Tardy; R Sahli; B Sordat; J Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

5.  The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells.

Authors:  R Takahashi; T Hashimoto; H J Xu; S X Hu; T Matsui; T Miki; H Bigo-Marshall; S A Aaronson; W F Benedict
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

6.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

7.  Thymocyte apoptosis induced by p53-dependent and independent pathways.

Authors:  A R Clarke; C A Purdie; D J Harrison; R G Morris; C C Bird; M L Hooper; A H Wyllie
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

8.  p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens.

Authors:  S D Morgenbesser; B O Williams; T Jacks; R A DePinho
Journal:  Nature       Date:  1994-09-01       Impact factor: 49.962

9.  Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.

Authors:  X Q Qin; D M Livingston; W G Kaelin; P D Adams
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

10.  Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells.

Authors:  G Del Bino; Z Darzynkiewicz
Journal:  Cancer Res       Date:  1991-02-15       Impact factor: 12.701

View more
  5 in total

1.  Retinoblastoma protein induction by HIV viremia or CCR5 in monocytes exposed to HIV-1 mediates protection from activation-induced apoptosis: ex vivo and in vitro study.

Authors:  Bethsebah Gekonge; Andrea D Raymond; Xiangfan Yin; Jay Kostman; Karam Mounzer; Ronald G Collman; Louise Showe; Luis J Montaner
Journal:  J Leukoc Biol       Date:  2012-06-13       Impact factor: 4.962

2.  Shift in monocyte apoptosis with increasing viral load and change in apoptosis-related ISG/Bcl2 family gene expression in chronically HIV-1-infected subjects.

Authors:  Sean C Patro; Sharmistha Pal; Yingtao Bi; Kenneth Lynn; Karam C Mounzer; Jay R Kostman; Ramana V Davuluri; Luis J Montaner
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

3.  RB activity alters checkpoint response and chemosensitivity in lung cancer lines.

Authors:  Michael F Reed; William A Zagorski; Erik S Knudsen
Journal:  J Surg Res       Date:  2007-07-19       Impact factor: 2.192

4.  RGS16, a novel p53 and pRb cross-talk candidate inhibits migration and invasion of pancreatic cancer cells.

Authors:  Miranda B Carper; James Denvir; Goran Boskovic; Donald A Primerano; Pier Paolo Claudio
Journal:  Genes Cancer       Date:  2014-11

5.  Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer.

Authors:  Hussein M Khaled; Abeer A Bahnassy; Amira A Raafat; Abdel-Rahman N Zekri; Maha S Madboul; Nadia M Mokhtar
Journal:  BMC Cancer       Date:  2009-01-26       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.